Novel effector monocytes against human RBC antigens invading rejected renal allografts.
A novel effector SPFC-MO may be involved in human renal allograft rejection, and the involvement of SPFC in rejected grafts may be reflected by the preoperative antidonor SPFC reactivity detected by the MLC-SPFC assay.
Ishibashi
M
M
Department of Urology, Osaka University Hospital, Japan.
Kokado
Y
Y
Takahara
S
S
Ichikawa
Y
Y
Sonoda
T
T
D004912:Erythrocytes / Q000276:immunology*; D006084:Graft Rejection; D006801:Humans; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation; D009000:Monocytes / Q000276:immunology*